Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo
Open Access
- 26 November 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 89 (3) , 586-594
Abstract
High-mobility group box 1 (HMGB1) is a nuclear protein actively secreted by immune cells and passively released by necrotic cells that initiates pro-inflammatory signalling through binding to the receptor for advance glycation end-products. HMGB1 has been established as a key inflammatory mediator during myocardial infarction, but the proximal mechanisms responsible for myocardial HMGB1 expression and release in this setting remain unclear. Here, we investigated the possible involvement of peroxynitrite, a potent cytotoxic oxidant formed during myocardial infarction, on these processes. The ability of peroxynitrite to induce necrosis and HMGB1 release in vitro was evaluated in H9c2 cardiomyoblasts and in primary murine cardiac cells (myocytes and non-myocytes). In vivo, myocardial HMGB1 expression and nitrotyrosine content (a marker of peroxynitrite generation) were determined following myocardial ischaemia and reperfusion in rats, whereas peroxynitrite formation was inhibited by two different peroxynitrite decomposition catalysts: 5,10,15,20-tetrakis(4-sulphonatophenyl) porphyrinato iron (III) (FeTPPS) or Mn(III)-tetrakis(4-benzoic acid) porphyrin chloride (MnTBAP). In all types of cells studied, peroxynitrite (100 μM) elicited significant necrosis, the loss of intracellular HMGB1, and its passive release into the medium. In vivo, myocardial ischaemia–reperfusion induced significant myocardial necrosis, cardiac nitrotyrosine formation, and marked overexpression of myocardial HMGB1. FeTPPS reduced nitrotyrosine, decreased infarct size, and suppressed HMGB1 overexpression, an effect that was similarly obtained with MnTBAP. These findings indicate that peroxynitrite represents a key mediator of HMGB1 overexpression and release by cardiac cells and provide a novel mechanism linking myocardial oxidative/nitrosative stress with post-infarction myocardial inflammation.Keywords
This publication has 50 references indexed in Scilit:
- Oxidants Positively or Negatively Regulate Nuclear Factor κB in a Context-dependent MannerJournal of Biological Chemistry, 2010
- Peroxynitrite Is the Major Species Formed from Different Flux Ratios of Co-generated Nitric Oxide and SuperoxideJournal of Biological Chemistry, 2010
- Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stressAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- The receptor for advanced glycation endproducts (RAGE) and cardiovascular diseaseExpert Reviews in Molecular Medicine, 2009
- INO-4885 [5,10,15,20-Tetra[N-(benzyl-4′-carboxylate)-2-pyridinium]-21 H,23 H-porphine Iron(III) Chloride], a Peroxynitrite Decomposition Catalyst, Protects the Heart against Reperfusion Injury in MiceThe Journal of Pharmacology and Experimental Therapeutics, 2009
- How dying cells alert the immune system to dangerNature Reviews Immunology, 2008
- Nitric Oxide and Peroxynitrite in Health and DiseasePhysiological Reviews, 2007
- Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivoFree Radical Biology and Medicine, 2006
- Peroxynitrite Is an Essential Component of Cytokines Production Mechanism in Human Monocytes through Modulation of Nuclear Factor-κB DNA Binding ActivityJournal of Biological Chemistry, 2002
- Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusionBritish Journal of Pharmacology, 2001